Understanding the time course of pharmacological effect: a PKPD approach.
about
An Algorithm and R Program for Fitting and Simulation of Pharmacokinetic and Pharmacodynamic Data.Population pharmacokinetic-pharmacodynamic modelling in oncology: a tool for predicting clinical response.Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challengesInterpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.Effects of idazoxan on alcohol pharmacokinetics and intoxication: a preliminary human laboratory study.Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers.Quantitative Systems Pharmacology: A Framework for Context.Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy.What do we learn from repeated population analyses?Population pharmacometrics in support of analgesics studies.Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach.Impact of disease, drug and patient adherence on the effectiveness of antiviral therapy in pediatric HIV.Altering ethanol pharmacokinetics to treat alcohol use disorder: Can you teach an old dog new tricks?Integrating biopharmaceutics risk assessment and in vivo absorption model in formulation development of BCS class I drug using the QbD approach.Noradrenergic targets for the treatment of alcohol use disorder.The clinical utility of pharmacometric models.
P2860
Q31119393-5D145335-479F-4E75-8F4F-95FFA06DC6F1Q34953673-0F39F8D7-23F9-4F1B-9563-1106A6958941Q34953705-44548A4B-261F-4606-91C5-C26B3F4F2F09Q34996894-C9DBD0E1-5DA0-4E10-9C5C-24763327D3D7Q35256306-7E7D04AA-8E0E-41E9-82D8-114665D046A0Q36801536-85B52288-B995-47FE-8441-DAB33537D8D1Q37200950-643A1C93-C520-4413-A49E-EAD3871EC668Q37512208-CFAB4377-94DD-4C6D-8F9A-3E2903CFF804Q38137268-7616731B-1FBE-416E-BBE2-FCECDC63EA0EQ38175171-CA29693F-10D5-4F4C-87FB-8195F74C0980Q39053849-037D46D0-3D17-4E7D-A38A-D26CC3E34F57Q39064765-32496390-0D2B-4969-A432-A56AA354A6ACQ39090733-F01C61F3-451B-4973-AC11-99EFB468CD1DQ47592497-F753B987-2BFC-4622-9EC2-213E7C48D99DQ49825421-3E6DFD2A-6CF9-4747-BD79-EBBDA3B65EDDQ52594703-421841A4-C6DE-49ED-B2EE-4CFDB437E3D6
P2860
Understanding the time course of pharmacological effect: a PKPD approach.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Understanding the time course of pharmacological effect: a PKPD approach.
@en
Understanding the time course of pharmacological effect: a PKPD approach.
@nl
type
label
Understanding the time course of pharmacological effect: a PKPD approach.
@en
Understanding the time course of pharmacological effect: a PKPD approach.
@nl
prefLabel
Understanding the time course of pharmacological effect: a PKPD approach.
@en
Understanding the time course of pharmacological effect: a PKPD approach.
@nl
P2093
P2860
P1476
Understanding the time course of pharmacological effect: a PKPD approach.
@en
P2093
Daniel F B Wright
Helen R Winter
Stephen B Duffull
P2860
P304
P356
10.1111/J.1365-2125.2011.03925.X
P407
P577
2011-06-01T00:00:00Z